Tag: #lifesciences

Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….

The European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…

Clinical trials are an expensive and risky business. The investment of time, resources and costs grows with progression through the…

A patent for an invention provides its owner with the right to exclude others from making, using, offering for sale…